Cullinan Therapeutics, Inc. (CGEM) Earnings
Cullinan Therapeutics, Inc. is expected to report next earnings on August 6, 2026 (in NaN days), with a consensus EPS estimate of $-0.81. CGEM has beaten EPS estimates in 9 of its last 12 reported quarters (average surprise +1.3% over the last four).
Next earnings
Aug 6, 2026in NaN days
EPS est $-0.81 · Revenue est $4M
Track record
Beat EPS in 9 of 12 quarters
Avg surprise +1.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-0.84 | $-0.75 | +10.3% | — | — |
| Mar 10, 2026 | $-0.81 | $-0.77 | +4.9% | — | — |
| Nov 6, 2025 | $-0.95 | $-0.77 | +18.9% | — | — |
| Aug 7, 2025 | $-0.83 | $-1.07 | -28.9% | — | — |
| May 8, 2025 | $-0.78 | $-0.74 | +5.1% | — | — |
| Feb 27, 2025 | $-0.75 | $-0.73 | +2.7% | — | — |
| Nov 7, 2024 | $-0.78 | $-0.69 | +11.5% | — | — |
| Aug 8, 2024 | $-0.73 | $-0.75 | -2.7% | — | — |
| May 15, 2024 | $-0.90 | $-0.86 | +4.4% | — | — |
| Mar 14, 2024 | $-0.96 | $-0.54 | +43.7% | — | — |
| Aug 10, 2023 | $-0.99 | $-0.82 | +17.2% | — | — |
| May 11, 2023 | $-0.84 | $-1.42 | -69.0% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.